Astrocytes & Amyloid

The relationship between astrocytes and amyloid has been suggested in some neurological diseases such as Alzheimer’s disease. Neuronal damage stimulates the activation of reactive astrocytes, which may the source of amyloid that forms in Alzheimer’s. Here is the latest research on astrocytes and amyloid.

September 17, 2020

Astrocyte remodeling in the beneficial effects of long-term voluntary exercise in Alzheimer's disease

Journal of Neuroinflammation
Irina BelayaKatja M Kanninen
August 4, 2020
Open Access

Cognitive improvements and reduction in amyloid plaque deposition by saikosaponin D treatment in a murine model of Alzheimer's disease

Experimental and Therapeutic Medicine
Li ZhouYa-Liang Zhao
September 2, 2020
Open Access

Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice

Journal of Neuroinflammation
Dan LiuHui Zhou
September 12, 2020
Open Access

Gallic Acid is a Dual α/β-Secretase Modulator that Reverses Cognitive Impairment and Remediates Pathology in Alzheimer Mice

The Journal of Biological Chemistry
Takashi MoriTerrence Town
September 4, 2020

The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease

Nature
Ji-Yeun HurYue-Ming Li
September 3, 2020

G-lymphatic, vascular and immune pathways for Aβ clearance cascade and therapeutic targets for Alzheimer's disease

Combinatorial Chemistry & High Throughput Screening
Saurav ChakrabortyDivakar Selvaraj
September 15, 2020

Neuronal Calcium Imaging, Excitability, and Plasticity Changes in the Aldh2-/- Mouse Model of Sporadic Alzheimer's Disease

Journal of Alzheimer's Disease : JAD
Adam O GhoweriOlivier Thibault
September 5, 2020

Decoding the Inter-relationship between Sleep Disorders and Alzheimer's disease Pathogenesis

CNS & Neurological Disorders Drug Targets
Zeba MueedNitesh Kumar Poddar
September 9, 2020

P38K and JNK pathways are induced byamyloid-β in astrocyte: implication of MAPK pathways in astrogliosis in Alzheimer's disease

Molecular and Cellular Neurosciences
Pampa SahaSubhas Chandra Biswas
September 7, 2020

APP Family Regulates Neuronal Excitability and Synaptic Plasticity but Not Neuronal Survival

Neuron
Sang Hun LeeJie Shen
September 15, 2020

Traumatic Injury Reduces Amyloid Plaque Burden in the Transgenic 5xFAD Alzheimer's Mouse Spinal Cord

Journal of Alzheimer's Disease : JAD
Tak-Ho ChuPeter K Stys
September 11, 2020
Open Access

Peroxiredoxin 6 mediates protective function of astrocytes in Aβ proteostasis

Molecular Neurodegeneration
Joanna E PankiewiczMartin J Sadowski
August 1, 2020
Open Access

The Neuroprotective Action of Amidated-Kyotorphin on Amyloid β Peptide-Induced Alzheimer's Disease Pathophysiology

Frontiers in Pharmacology
Rita F BeloAna M Sebastião
August 26, 2020
Open Access

Acoustofluidic assembly of 3D neurospheroids to model Alzheimer's disease

The Analyst
Hongwei CaiFeng Guo

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/astrocytes-amyloid/7301b432-adb0-4f28-afae-1836ce5071f7